Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
Mapped by CNV |
|
RNF144B |
ring finger protein 144B |
Mapped by LD-proxy |
|
TP53AIP1 |
tumor protein p53 regulated apoptosis inducing protein 1 |
Mapped by significant region |
TAS[11030628]
|
C11orf82 |
chromosome 11 open reading frame 82 |
Mapped by significant region |
|
TAX1BP1 |
Tax1 (human T-cell leukemia virus type I) binding protein 1 |
Mapped by significant region |
|
DFNA5 |
deafness, autosomal dominant 5 |
Mapped by CNV; Mapped by significant region |
|
GJA1 |
gap junction protein, alpha 1, 43kDa |
Mapped by significant region |
|
CASP5 |
caspase 5, apoptosis-related cysteine peptidase |
Mapped by significant region |
|
SPATA4 |
spermatogenesis associated 4 |
Mapped by LD-proxy |
IEP[12019456]
|
TGFBR1 |
transforming growth factor, beta receptor 1 |
Mapped by significant region |
|
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
Mapped by significant region |
|
MAP1S |
microtubule-associated protein 1S |
Mapped by PBA pathway |
IDA[12762840]
|
MAPK3 |
mitogen-activated protein kinase 3 |
Mapped by CNV |
|
GZMH |
granzyme H (cathepsin G-like 2, protein h-CCPX) |
Mapped by significant region |
NAS[2402757]
|
DNAJB13 |
DnaJ (Hsp40) homolog, subfamily B, member 13 |
Mapped by CNV; Mapped by significant region |
IEP[12673577]
|
GZMB |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
Mapped by significant region |
|
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
Mapped by significant region |
|
WWOX |
WW domain containing oxidoreductase |
Mapped by significant region |
|
EGLN3 |
egl nine homolog 3 (C. elegans) |
Mapped by LD-proxy; Mapped by literature SNP |
|
GATA6 |
GATA binding protein 6 |
Mapped by significant region |
|
BIRC2 |
baculoviral IAP repeat containing 2 |
Mapped by significant region |
|
PSMB7 |
proteasome (prosome, macropain) subunit, beta type, 7 |
Mapped by significant region |
|
ZBTB16 |
zinc finger and BTB domain containing 16 |
Mapped by significant region |
NAS[9294197]
|
PRKD1 |
protein kinase D1 |
Mapped by significant region |
|
AATF |
apoptosis antagonizing transcription factor |
Mapped by CNV |
|
MIEN1 |
migration and invasion enhancer 1 |
Mapped by LD-proxy |
|
PSMA8 |
proteasome (prosome, macropain) subunit, alpha type, 8 |
Mapped by significant region |
|
KRT18 |
keratin 18 |
Mapped by PBA pathway |
|
AATK |
apoptosis-associated tyrosine kinase |
Mapped by LD-proxy |
|
UBC |
ubiquitin C |
Mapped by CNV |
|
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
Mapped by significant region |
|
SGK1 |
serum/glucocorticoid regulated kinase 1 |
Mapped by significant region |
|
CADM1 |
cell adhesion molecule 1 |
Mapped by significant region |
|
BRMS1 |
breast cancer metastasis suppressor 1 |
Mapped by significant region |
|
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
Mapped by significant region |
|
PRKCB |
protein kinase C, beta |
Mapped by significant region |
|
MAPT |
microtubule-associated protein tau |
Mapped by LD-proxy; Mapped by PBA pathway |
|
AVEN |
apoptosis, caspase activation inhibitor |
Mapped by CNV |
|
ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
Mapped by significant region |
|
EI24 |
etoposide induced 2.4 mRNA |
Mapped by significant region |
|
RNF130 |
ring finger protein 130 |
Mapped by CNV |
|
ARHGEF12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
Mapped by significant region |
|
PSMG2 |
proteasome (prosome, macropain) assembly chaperone 2 |
Mapped by CNV |
|
GREM1 |
gremlin 1 |
Mapped by CNV; Mapped by significant region |
|
MLL |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) |
Mapped by significant region |
|
TJP1 |
tight junction protein 1 (zona occludens 1) |
Mapped by CNV; Mapped by significant region |
|
ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
Mapped by PBA pathway |
|
BCL7C |
B-cell CLL/lymphoma 7C |
Mapped by CNV |
|
PSME2 |
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
Mapped by significant region |
|
RTN3 |
reticulon 3 |
Mapped by significant region |
|
SHF |
Src homology 2 domain containing F |
Mapped by CNV |
|
TRAF1 |
TNF receptor-associated factor 1 |
Mapped by significant region |
|
BAD |
BCL2-associated agonist of cell death |
Mapped by significant region |
|
RTN4 |
reticulon 4 |
Mapped by CNV |
NAS[11126360]
|
MCF2L |
MCF.2 cell line derived transforming sequence-like |
Mapped by CNV |
|
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
Mapped by CNV |
IDA[18371312]; IPI[7954800]
|
TMEM219 |
transmembrane protein 219 |
Mapped by CNV |
|
PSME1 |
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
Mapped by significant region |
|
UBB |
ubiquitin B |
Mapped by significant region |
|
ARHGEF4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
Mapped by CNV; Mapped by significant region |
|
SMNDC1 |
survival motor neuron domain containing 1 |
Mapped by PBA pathway |
|
DAB2 |
disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) |
Mapped by significant region |
|
TAOK2 |
TAO kinase 2 |
Mapped by CNV |
NAS[10660600]
|
API5 |
apoptosis inhibitor 5 |
Mapped by PBA pathway |
|
MAPK1 |
mitogen-activated protein kinase 1 |
Mapped by LD-proxy |
|
ADORA2A |
adenosine A2a receptor |
Mapped by CNV |
TAS[7818494]
|
CASP1 |
caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) |
Mapped by significant region |
TAS[7876192]
|
PDCL3 |
phosducin-like 3 |
Mapped by CNV |
|
POLR2G |
polymerase (RNA) II (DNA directed) polypeptide G |
Mapped by significant region |
|
DAXX |
death-domain associated protein |
Mapped by LD-proxy; Mapped by PBA pathway |
TAS[15572661]
|
ARF6 |
ADP-ribosylation factor 6 |
Mapped by PBA pathway |
|
ERN2 |
endoplasmic reticulum to nucleus signaling 2 |
Mapped by significant region |
|
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
Mapped by significant region |
IMP[17599062]
|
PSMD7 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 |
Mapped by significant region |
|
BLID |
BH3-like motif containing, cell death inducer |
Mapped by significant region |
|
PAK7 |
p21 protein (Cdc42/Rac)-activated kinase 7 |
Mapped by CNV |
|
CARD6 |
caspase recruitment domain family, member 6 |
Mapped by significant region |
|
DSG3 |
desmoglein 3 |
Mapped by significant region |
|
C22orf29 |
chromosome 22 open reading frame 29 |
Mapped by CNV |
|
NEK6 |
NIMA (never in mitosis gene a)-related kinase 6 |
Mapped by significant region |
|
BIRC6 |
baculoviral IAP repeat containing 6 |
Mapped by CNV |
|
GSN |
gelsolin |
Mapped by PBA pathway; Mapped by significant region |
|
PERP |
PERP, TP53 apoptosis effector |
Mapped by significant region |
|
PDCD10 |
programmed cell death 10 |
Mapped by CNV |
|
G2E3 |
G2/M-phase specific E3 ubiquitin protein ligase |
Mapped by significant region |
|
KLF11 |
Kruppel-like factor 11 |
Mapped by significant region |
|
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
Mapped by significant region |
IDA[10449408]
|
DSG2 |
desmoglein 2 |
Mapped by significant region |
IDA[17559062]
|
SQSTM1 |
sequestosome 1 |
Mapped by CNV |
|
APC |
adenomatous polyposis coli |
Mapped by LD-proxy; Mapped by PBA pathway |
|
PSMD5 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 |
Mapped by significant region |
|
ATG5 |
ATG5 autophagy related 5 homolog (S. cerevisiae) |
Mapped by CNV |
|
MAPK7 |
mitogen-activated protein kinase 7 |
Mapped by significant region |
|
PAK1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
Mapped by significant region |
|
OPA1 |
optic atrophy 1 (autosomal dominant) |
Mapped by CNV |
|
PDCD7 |
programmed cell death 7 |
Mapped by PBA pathway |
|
DSG1 |
desmoglein 1 |
Mapped by significant region |
|
BIRC3 |
baculoviral IAP repeat containing 3 |
Mapped by significant region |
|
CYCS |
cytochrome c, somatic |
Mapped by CNV; Mapped by significant region |
IDA[8689682]
|
FADD |
Fas (TNFRSF6)-associated via death domain |
Mapped by significant region |
|
PDCD4 |
programmed cell death 4 (neoplastic transformation inhibitor) |
Mapped by LD-proxy |
NAS[12054647]
|